Search Trials
Conditions
Learn
About

Data source: ClinicalTrials.gov

This site is for informational purposes only and does not provide medical advice, diagnosis, or treatment. Always consult your healthcare provider.

Intestinal Low-Dose Radiotherapy Plus Immunochemotherapy for Conversion of Borderline Resectable/Unresectable Esophageal Squamous Cell Carcinoma | MicrobiomeTrials

← Back to trials

NCT07339488

Intestinal Low-Dose Radiotherapy Plus Immunochemotherapy for Conversion of Borderline Resectable/Unresectable Esophageal Squamous Cell Carcinoma

RecruitingPHASE2INTERVENTIONAL

Trial Details

Start: 2025-12-05Est. Completion: 2028-11-01

Enrollment target: 43 participants

Locations

Cancer Hospital, Shantou University Medical College, Shantou, Guangdong, China

Contact

Chuangzhen Chenczchen2@stu.edu.cn +86 13923995569

Other microbiome trials you might be interested in

Adebrelimab Combined With Neoadjuvant Chemotherapy in Borderline Resectable Locally Advanced Esophageal Squamous Cell CarcinomaPhase 2Recruiting

Esophageal Squamous Cell Carcinoma (ESCC)

This clinical trial aims to preliminarily evaluate the efficacy and safety of adebrelimab combined with albumin-bound pa…

Guangzhou, ChinaEst. completion Jan 1, 2028

View Trial →

AB801 in Combination With Chemotherapy and Immunotherapy for the Treatment of Patients With Borderline Resectable, Locally Advanced or Metastatic Cholangiocarcinoma or Pancreatic CancerPhase 1Recruiting

Borderline Resectable Pancreatic Ductal AdenocarcinomaLocally Advanced CholangiocarcinomaLocally Advanced Pancreatic AdenocarcinomaMetastatic CholangiocarcinomaMetastatic Pancreatic AdenocarcinomaStage II Pancreatic Cancer AJCC v8Stage III Pancreatic Cancer AJCC v8Stage IV Pancreatic Cancer AJCC v8

This phase I trial tests the safety, side effects, best dose and effectiveness of AB801 in combination with chemotherapy…

Los Angeles, United StatesEst. completion Jun 1, 2027

View Trial →

Apply or Learn More on ClinicalTrials.gov

MicrobiomeTrials does not provide medical advice. Always consult your doctor before joining a clinical trial.